Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI |
| |
Authors: | Pivi Harjunen Vesa-Pekka Lehto Krista Martimo Eero Suihko Tapio Lankinen Petteri Paronen Kristiina Jrvinen |
| |
Institution: | a Department of Pharmaceutics, University of Kuopio, P.O. Box 1627, FIN-70211, Kuopio, Finland b Department of Physics, University of Turku, FIN-20014, Turku, Finland c Focus Inhalation Oy, P.O. Box 980, FIN-20101, Turku, Finland |
| |
Abstract: | Drug–carrier particle interactions greatly affect the detachment of drug from the carrier in inhalation powders. In this study, a novel multiple dose, reservoir-based Taifun® was used as a dry powder inhaler, and the effects of carrier physical properties were evaluated on the pulmonary deposition of budesonide, along with physical stability of the inhalation powder. In this study, untreated commercial preparation of -lactose monohydrate, highly amorphous spray dried lactose, crystallized spray dried lactose, Flowlac-100® and Flowlac-100® mixed with crystalline micronized lactose were used as carriers. Dry powder formulations were prepared by the suspension method, where the budesonide–carrier ratio was 1:15.1 (w/w). Carriers and formulations were initially characterized, and again after 1 month’s storage at 40 °C/75% RH. The physical properties of the carriers strongly affected the pulmonary deposition of budesonide and the physical stability of the inhalation powder. Initially, amorphous contents of the carriers were 0–64%, but spontaneous crystallisation of the amorphous lactose occurred during storage and, thus all carriers were 100% crystalline after storage. When compared to an untreated -lactose monohydrate, the highly amorphous spray dried lactose and Flowlac-100® did not improve aerosol performance of the inhalation powder. When crystalline spray dried lactose was used as a carrier, the highest RF% values were achieved, and RF % values did not alter during storage but the emitted budesonide dose was lower than the theoretical dose. When Flowlac-100® mixed with crystalline micronized lactose was used as a carrier, the emitted budesonide dose was close to the theoretical dose, and high RF % values were achieved but these changed during storage. |
| |
Keywords: | Inhalation powder Multiple dose DPI Lactose Budesonide Spray drying Taifun® |
本文献已被 ScienceDirect 等数据库收录! |
|